Skip to main content
See every side of every news story
Published loading...Updated

Roche’s Genentech more than doubles North Carolina facility investment to $2B

The 700,000-square-foot project broke ground in August and is set to produce weight-loss treatments by 2029 in Holly Springs, a growing biopharmaceutical hub.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

constructiondive.com broke the news in on Friday, January 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal